1. Home
  2. /
  3. COA in the News

COA in the News


Mar 18

2019

The Necessity of Addressing Cost Burden on Patients

Drug prices may not be sustainable, but what really matters is not the price of the drug, but what the cost is to patients, said Ted Okon, executive director of the Community Oncology Alliance, and Daniel Klein, president and executive director of the Patient Access Network (PAN) Foundation, during a panel at the University of

Read more

Mar 15

2019

Will CMS’ CAR T-cell Therapy Payment Plan Leave Out Community Practices?

CMS’ proposal last month that any patients seeking cancer treatment with chimeric antigen receptor (CAR) T-cell therapy be enrolled in clinical trials or registries has drawn a variety of responses. But there’s a single word that could mean plenty for patients in large swaths of the country:

Read more

Mar 13

2019

Impact of Government Policies and Proposals on Community Oncologists

The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.

Read more

Mar 13

2019

Advocate ‘Walks the Talk’ Regarding Cancer Clinical Trials

Clinical trials are about more than just collecting data – they’re about survivorship and family. This was the focus of Rose Gerber’s talk at the CURE Patient-Focused meeting at the 36th Annual Miami Breast Cancer Conference.

Read more

Mar 13

2019

Sharing Experiences From Clinical Trials: ‘Let’s Walk the Talk’

Clinical trials are about more than just collecting data – they’re about survivorship and family. This was the focus of Rose Gerber’s talk at the CURE Patient-Focused meeting at the 36th Annual Miami Breast Cancer Conference.

Read more

Feb 28

2019

PBM Delays for Cancer Drugs May Risk Lives, Warn Oncologists

The patient had metastatic kidney cancer, and his oncologist was seeking to treat him with sunitinib malate (Sutent, Pfizer), a preferred first-line oral therapy. But the patient's pharmacy benefit manager (PBM) refused to cover the cost of the medication. The PBM told the oncologist that the patient's kidney must first be removed.

Read more

Feb 21

2019

Participating Practices Commend CMS for OCM Changes

As the oncology care model (OCM), a 5-year pilot payment project from the Centers for Medicare & Medicaid Services (CMS) involving oncology practices, reaches its halfway mark, a fresh round of performance feedback intended to guide and evaluate its progress has been issued. Although many participants are critical of the structure of the OCM, they

Read more

Feb 21

2019

CMS’ Healthcare Reform Efforts Make Waves

Although some policy efforts on healthcare reform fell by the wayside when the Obama administration left office, the past 2 years under President Donald J. Trump have seen much action in this regard, making it an active time on Capitol Hill for lobbyists representing the oncology industry. The charge into healthcare reform over the past

Read more

Feb 6

2019

Heightened Risk for Natural Disasters Necessitates Advance Preparation in Oncology Community

When hurricane Irma hit Florida in 2017, it churned its way up the western coast of the state and moved directly over the largest cluster of independent practices in the Florida Cancer Specialists (FCS) group. Nevertheless, the chain was able to reopen 86 of its 100 offices within just a few days of the storm’s

Read more

Feb 4

2019

HHS Proposes Scrapping Rebates to PBMs, Giving Discounts to Patients

Secretary of Health and Human Services (HHS) Alex Azar announced radical changes to the way drugs are paid for in a new proposed rule aimed at lowering out-of-pocket costs for patients, especially seniors.

Read more